“The Effectiveness of Semaglutida in Preventing Cardiovascular Risks Associated With Obesity and Diabetes”. Revista Eletrônica Acervo Médico 25 (October 29, 2025): e21868. Accessed November 3, 2026. https://acervomais.com.br/medico/article/view/21868.